Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action
- 1 June 1999
- journal article
- review article
- Published by Elsevier in International Journal for Parasitology
- Vol. 29 (6) , 833-837
- https://doi.org/10.1016/s0020-7519(99)00044-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cysteine protease inhibitors as chemotherapy for parasitic infectionsBioorganic & Medicinal Chemistry, 1999
- Leishmania major:Molecular Modeling of Cysteine Proteases and Prediction of New Nonpeptide InhibitorsExperimental Parasitology, 1997
- Covalent modification of the active site threonine of proteasomal β subunits and theEscherichia colihomolog HslV by a new class of inhibitorsProceedings of the National Academy of Sciences, 1997
- Small synthetic inhibitors of cysteine proteasesPerspectives in Drug Discovery and Design, 1996
- Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivoMolecular and Biochemical Parasitology, 1996
- Proteases from Trypanosoma brucei bruceiEuropean Journal of Biochemistry, 1996
- The Crystal Structure of Cruzain: A Therapeutic Target for Chagas' DiseaseJournal of Molecular Biology, 1995
- THE PROTEASES AND PATHOGENICITY OF PARASITIC PROTOZOAAnnual Review of Microbiology, 1993
- Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.Journal of Clinical Investigation, 1993
- Analysis of the proteinases of Trypanosoma bruceiJournal of General Microbiology, 1990